Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ENOS Antikörper

NOS3 Reaktivität: Human ELISA, IHC Wirt: Maus Monoclonal 6H2 unconjugated
Produktnummer ABIN969097
  • Target Alle ENOS (NOS3) Antikörper anzeigen
    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
    Reaktivität
    • 273
    • 153
    • 151
    • 13
    • 10
    • 8
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 278
    • 29
    • 1
    Maus
    Klonalität
    • 280
    • 28
    Monoklonal
    Konjugat
    • 118
    • 25
    • 17
    • 14
    • 10
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    Dieser ENOS Antikörper ist unkonjugiert
    Applikation
    • 254
    • 104
    • 97
    • 91
    • 78
    • 53
    • 37
    • 25
    • 25
    • 25
    • 12
    • 8
    • 7
    • 4
    • 3
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC)
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human eNOS expressed in E. coli.
    Klon
    6H2
    Isotyp
    IgG1
    Top Product
    Discover our top product NOS3 Primärantikörper
  • Applikationshinweise
    ELISA: 1:10000, IHC: 1:200 - 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Moreno: "Genetic polymorphisms and haplotypes of eNOS in breast cancer." in: Breast cancer research and treatment, Vol. 109, Issue 1, pp. 181-2, (2008) (PubMed).

    Lahiri, Martin: "Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line." in: Oncology reports, Vol. 12, Issue 5, pp. 1007-11, (2004) (PubMed).

  • Target
    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
    Andere Bezeichnung
    eNOS (NOS3 Produkte)
    Synonyme
    ECNOS antikoerper, eNOS antikoerper, 2310065A03Rik antikoerper, Nos-3 antikoerper, ecNOS antikoerper, EC-NOS antikoerper, NOSIII antikoerper, cNOS antikoerper, NOS antikoerper, NOS3 antikoerper, eNos antikoerper, ENOS antikoerper, nitric oxide synthase 3 antikoerper, nitric oxide synthase 3, endothelial cell antikoerper, NOS3 antikoerper, Nos3 antikoerper, nos3 antikoerper
    Hintergrund

    Description: Endothelial nitric-oxide synthase (eNOS), also known as NOS3, it is an important enzyme in the cardiovascular system. It is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm.

    Aliases: ECNOS, NOS3

    Molekulargewicht
    133 kDa
    Gen-ID
    4846
    HGNC
    4846
    Pathways
    ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Sie sind hier:
Kundenservice